EUS in Inflammatory Diseases of the Pancreas

Endosonography

Volumn , Issue , 2011, Pages 127-147

  Romagnuolo, Joseph ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054709899     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0805-9.00013-3     Document Type: Chapter

References (182)

1. Hisanaga K., Hisanaga A., Nagata K., Ichie Y. High speed rotating scanner for transgastric sonography. AJR Am J Roentgenol 1980, 135:627-639.
2. DiMagno E.P., Buxton J.L., Regan P.T., et al. Ultrasonic endoscope. Lancet 1980, 22:629-631.
3. DiMagno E.P., Regan P.T., Clain J.E., et al. Human endoscopic ultrasonography. Gastroenterology 1982, 83(4):824-829.
4. Snady H. Endoscopic ultrasonography in benign pancreatic disease. Surg Clin North Am 2001, 81(2):329-344.
5. Inui K., Nakazawa S., Yoshino J., Okushima K., Nakamura Y. Endoluminal ultrasonography for pancreatic diseases. Gastroenterol Clin North Am 1999, 28(3):771-781.
6. Clain J.E., Pearson R.K. Diagnosis of chronic pancreatitis: is a gold standard necessary?. Surg Clin North Am 1999, 79:829-845.
7. Raimondo M., Wallace M.B. Diagnosis of early chronic pancreatitis by endoscopic ultrasound: are we there yet?. JOP 2004, 5(1):1-7.
8. Etemab B., Whitcomb D.C. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001, 120:682-707.
9. Bhutani M.S. Endoscopic ultrasound in pancreatic diseases: Indications, limitations and the future. Gastroenterol Clin North Am 1999, 28:747-770.
10. Wallace M.B., Hawes R.H. Endoscopic ultrasound in the evaluation and treatment of chronic pancreatitis. Pancreas 2001, 23(1):26-35.
11. Dancygier H. Endoscopic ultrasonography in chronic pancreatitis. Gastrointest Endosc Clin N Am 1995, 5:795-804.
12. Wiersema M.J., Wiersema L.M. Endosonography of the pancreas: normal variation versus changes of early chronic pancreatitis. Gastrointest Endosc Clin N Am 1995, 5:487-496.
13. Kahl S., Glasbrenner B., Zimmerman S., Malfertheiner P. Endoscopic ultrasound in pancreatic diseases. Dig Dis 2002, 20:120-126.
14. Finkelberg D.L., Sahani D., Deshpande V., Brugge W.R. Autoimmune pancreatitis. N Engl J Med 2006, 355(25):2670-2676.
15. Catalano M.F., Sahai A., Levy M., et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc 2009, 69(7):1251-1261.
16. Forsmark C.E. Chronic pancreatitis. Sleisenger & Fordtran's Gastrointestinal and Liver Disease 2002, 943-969. Elsevier, Philadelphia. 7th ed. M. Feldman, W.O.J. Tschumy, L.S. Friedman, M.H. Sleisenger (Eds.).
17. Adler D.G., Lichtenstein D., Baron T.H., et al. The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc 2006, 63(7):933-937.
18. Chari S.T., Longnecker D.S., Kloppel G. The diagnosis of autoimmune pancreatitis: a Western perspective. Pancreas 2009, 38(8):846-848.
19. Otsuki M., Chung J.B., Okazaki K., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43(6):403-408.
20. Okazaki K., Kawa S., Kamisawa T., et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009, 38(8):849-866.
21. DiMagno E.P., Chari S. Acute pancreatitis. Sleisenger & Fordtran's Gastrointestinal and Liver Disease 2002, 913-942. Elsevier, Philadelphia. 7th ed. M. Feldman, W.O.J. Tschumy, L.S. Friedman, M.H. Sleisenger (Eds.).
22. Wilcox C.M., Varadarajulu S., Eloubeidi M. Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. Gastrointest Endosc 2006, 63(7):1037-1045.
23. Burns P.N., Wilson S.R. Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q 2006, 22(1):5-13.
24. Sugiyama M., Haradome H., Atomi Y. Magnetic resonance imaging for diagnosing chronic pancreatitis. J Gastroenterol 2007, 42(suppl 17):108-112.
25. Catalano M.F., Lahoti S., Geenen J.E., Hogan W.J. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998, 48(1):11-17.
26. Wiersema M.J., Hawes R.H., Lehman G., et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993, 25:555-564.
27. Wallace M.B., Hawes R.H., Durkalski V., et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest Endosc 2001, 53(3):294-299.
28. Sahai A.V., Mishra G., Penman I.D., et al. EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc 2000, 52:153-159.
29. Savides T.J., Gress F.G., Zaidi S.A., et al. Detection of embryologic ventral pancreatic parenchyma with endoscopic ultrasound. Gastrointest Endosc 1996, 43:14-19.
30. Donald J.J., Shorvon P.J., Lees W.R. A hypoechoic area within the head of the pancreas: a normal variant. Clin Radiol 1990, 41:337-338.
31. Atri M., Nazarnia S., Mehio A., et al. Hypoechogenic embryologic ventral aspect of the head and uncinate process of the pancreas: in vitro correlation of US with histopathologic findings. Radiology 1994, 190:441-444.
32. Axon A.T., Classen M., Cotton P.B., et al. Pancreatography in chronic pancreatitis: international definitions. Gut 1984, 25:1107-1112.
33. Gillams A., Pereira S., Webster G., Lees W. Correlation of MRCP quantification (MRCPQ) with conventional non-invasive pancreatic exocrine function tests. Abdom Imaging 2008, 33(4):469-473.
34. Gillams A.R., Lees W.R. Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Eur Radiol 2007, 17(11):2984-2990.
35. Cheon Y.K., Cho K.B., Watkins J.L., et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc 2007, 65(3):385-393.
36. Sahai A.V., Zimmerman M., Aabakken L., et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998, 48(1):18-25.
37. International Working Group for Minimum Standard Terminology for Gastrointestinal Endosonography. Reproduction of minimum standard terminology in gastrointestinal endosonography. Dig Endosc 1998, 10:158-184.
38. World Organisation of Digestive Endoscopy (OMED) Committee of Documentation and Standardization Minimum standard terminology (MST v 3.0) 2009, Accessed May 19, 2010. http://www.omed.org/index.php/resources/re_mst/, 3.0 ed.
39. Romagnuolo J., Joseph L., Barkun A.N. Interpretation of diagnostic tests. Surgical Arithmetic: Epidemiological, Statistical, and Outcome-Based Approach to Surgical Practice 2000, 64-83. Georgetown, Tex, Landes Bioscience. L. Rosenberg, L. Joseph, A.N. Barkun (Eds.).
40. Altman D.G. Practical Statistics for Medical Students 1991, Chapman and Hall, London.
41. Landis J.R., Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977, 33(2):363-374.
42. Fleiss J.L. Statistical Methods for Rates and Proportions 1981, John Wiley & Sons, New York. 2nd ed.
43. Lau J.Y., Sung J.J., Chan A.C., et al. Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc 1997, 46:33-36.
44. von Kummer R., Holle R., Gizyska U., et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroradiol 1996, 17:1743-1748.
45. Lok C.E., Moragan C.D., Ranganathan N. The accuracy and interobserver agreement in detecting the "gallop sounds" by cardiac auscultation. Chest 1998, 114:1283-1288.
46. Takehara Y., Ichijo K., Tooyama N., et al. Breath-hold MR cholangiopancreatography with a long-echo-train fast spin-echo sequence and a surface coil in chronic pancreatitis. Radiology 1994, 192(1):73-78.
47. Lieb J., Palma D., Leblanc J., et al. Intraobserver agreement and variability Among endosonographers for EUS features of chronic pancreatitis [abstract]. Gastrointest Endosc 2009, 69:AB239.
48. Reuben A., Johnson A.L., Cotton P.B. Is pancreatogram interpretation reliable? A study of observer variation and error. Br J Radiol 1978, 51(612):956-962.
49. Romagnuolo J. EUS in inflammatory disease of the pancreas. Endosonography 2006, Vol 1:155-176. Elsevier, London. R.H. Hawes, P. Fockens (Eds.).
50. Chong A.K., Hawes R.H., Hoffman B.J., et al. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest Endosc 2007, 65(6):808-814.
51. Morris-Stiff G., Webster P., Frost B., et al. Endoscopic ultrasound reliably identifies chronic pancreatitis when other imaging modalities have been non-diagnostic. JOP 2009, 10(3):280-283.
52. Varadarajulu S., Eltoum I., Tamhane A., Eloubeidi M.A. Histopathologic correlates of noncalcific chronic pancreatitis by EUS: a prospective tissue characterization study. Gastrointest Endosc 2007, 66(3):501-509.
53. Kahl S., Glasbrenner B., Leodolter A., et al. EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. Gastrointest Endosc 2002, 55(4):507-511.
54. Rajan E., Clain J.E., Levy M.J., et al. Age-related changes in the pancreas identified by EUS: a prospective evaluation. Gastrointest Endosc 2005, 61(3):401-406.
55. Chong A.K., Romagnuolo J. Gender-related changes in the pancreas detected by EUS. Gastrointest Endosc 2005, 62(3):475.
56. Thuler F.P., Costa P.P., Paulo G.A., et al. Endoscopic ultrasonography and alcoholic patients: can one predict early pancreatic tissue abnormalities?. JOP 2005, 6(6):568-574.
57. Yusoff I.F., Sahai A.V. A prospective, quantitative assessment of the effect of ethanol and other variables on the endosonographic appearance of the pancreas. Clin Gastroenterol Hepatol 2004, 2(5):405-409.
58. Joseph L., Gyorkos T.W., Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol 1995, 141:263-272.
59. Fekete P.S., Nunez C., Pitlik D.A. Fine-needle aspiration biopsy of the pancreas: a study of 61 cases. Diagn Cytopathol 1986, 2:301-306.
60. Hollerbach S., Klamann A., Topalidis T., Schmiegel W.H. Endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA) cytology for diagnosis of chronic pancreatitis. Endoscopy 2001, 33(10):824-831.
61. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97(10):2614-2618.
62. Romagnuolo J., Schiller D., Bailey R.J. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002, 97:1113-1126.
63. Hayakawa T., Kondo T., Shibata T., et al. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol 1992, 87:1170-1174.
64. Research Committee for Chronic Pancreatitis, Japanese Society of Gastroenterology Clinical Diagnostic Criteria for Chronic Pancreatitis 1984, Tokyo, Igakutosho. S. Yamagata (Ed.).
65. Heij H.A., Obertop H., van Blankenstein M., et al. Relationship between functional and histological changes in chronic pancreatitis. Dig Dis Sci 1986, 31:1009-1013.
66. Heij H.A., Obertop H., van Blankenstein M., et al. Comparison of endoscopic retrograde pancreatography with functional and histologic changes in chronic pancreatitis. Acta Radiol 1987, 28:289-293.
67. Hardt P.D., Marzeion A.M., Schnell-Kretschmer H., et al. Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas 2002, 25(1):e6-e9.
68. Loser C., Mollgaard A., Folsch U.R. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996, 39(4):580-586.
69. Lankisch P.G., Schmidt I., Konig H., et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998, 42(4):551-554.
70. Lomas DJ, Bearcroft PW, Gimson AE. MR cholangiopancreatography: prospective comparison of a breath-hold 2D projection technique with diagnostic ERCP. Eur Radiol. 1411;9(7):1411-1417.
71. Manfredi R., Costamagna G., Brizi M.G., et al. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 2000, 214(3):849-855.
72. Calvo M.M., Bujanda L., Calderon A., et al. Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct. Am J Gastroenterol 2002, 97:347-353.
73. Alcaraz M.J., De la Morena E.J., Polo A., et al. A comparative study of magnetic resonance cholangiography and direct cholangiography. Rev Esp Enferm Dig 2000, 92(7):427-438.
74. Czako L., Endes J., Takacs T., et al. Evaluation of pancreatic exocrine function by secretin-enhanced magnetic resonance cholangiopancreatography. Pancreas 2001, 23(3):323-328.
75. Kalapala R., Sunitha L., Nageshwar R.D., et al. Virtual MR pancreatoscopy in the evaluation of the pancreatic duct in chronic pancreatitis. JOP 2008, 9(2):220-225.
76. Buscail L., Escourrou J., Moreau J., et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas 1995, 10:251-257.
77. Begg C.B. Biases in the assessment of diagnostic tests. Stat Med 1987, 6:411-423.
78. Lachs M.S., Nachamkin I., Edelstein P.H., et al. Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med 1992, 117(2):135-140.
79. Chowdhury R., Bhutani M.S., Mishra G., et al. Comparative analysis of direct pancreatic function testing versus morphological assessment by endoscopic ultrasonography for the evaluation of chronic unexplained abdominal pain of presumed pancreatic origin. Pancreas 2005, 31(1):63-68.
80. DeWitt J., McGreevy K., LeBlanc J., et al. EUS-guided Trucut biopsy of suspected nonfocal chronic pancreatitis. Gastrointest Endosc 2005, 62(1):76-84.
81. Ammann R.W., Heitz P.U., Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996, 111(1):224-231.
82. Bhutani M.S., Ahmed I., Verma D., et al. An animal model for studying endoscopic ultrasound changes of early chronic pancreatitis with histologic correlation: a pilot study. Endoscopy 2009, 41(4):352-356.
83. Chen R.Y.M., Hino S., Aithal G.P., et al. Endoscopic ultrasound (EUS) features of chronic pancreatitis predate subsequent development of abnormal endoscopic retrograde pancreatogram (ERP) [abstract]. Gastrointest Endosc 2002, 55:AB242.
84. Hastier P., Buckley M.J., Francois E., et al. A prospective study of pancreatic diseases in patients with alcoholic cirrhosis: comparative diagnostic value of ERCP and EUS and long-term significance of isolated parenchymal abnormalities. Gastrointest Endosc 1999, 49:705-709.
85. Pungpapong S., Wallace M.B., Woodward T.A., et al. Accuracy of endoscopic ultrasonography and magnetic resonance cholangiopancreatography for the diagnosis of chronic pancreatitis: a prospective comparison study. J Clin Gastroenterol 2007, 41(1):88-93.
86. Singh P., Vela S., Agrawal D., et al. Long term outcome in patients with endosonographic findings suggestive of mild chronic pancreatitis [abstract]. Gastrointest Endosc 2004, 59:AB231.
87. Delhaze M., Jonard P., Gigot J.F., et al. [Chronic pancreatitis and pancreatic cancer: an often difficult differential diagnosis]. Acta Gastroenterol Belg 1989, 52:458-466. [in French].
88. DelMaschio A., Vanzulli A., Sironi S., et al. Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology 1991, 178:95-99.
89. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Pancreatitis and the risk of cancer. N Engl J Med 1993, 328:1433-1437.
90. Becker D., Strobel D., Bernatik T., Hahn E.G. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001, 53(7):784-789.
91. McGuire D.E., Venu R.P., Brown R.D., et al. Brush cytology for pancreatic carcinoma: an analysis of factors influencing results. Gastrointest Endosc 1996, 44(3):300-304.
92. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999, 49(3 Pt 1):322-327.
93. Kochman M.L. EUS in pancreatic cancer. Gastrointest Endosc 2002, 56:S6-S12.
94. Mallery J.S., Centeno B.A., Hahn P.F., et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002, 56:218-224.
95. Barthet M., Portal I., Boujaoude J., et al. Endoscopic ultrasonographic diagnosis of pancreatic cancer complicating chronic pancreatitis. Endoscopy 1996, 28(6):487-491.
96. Sackett D.L., Haynes R.B., Guyatt G.H., Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine 1991, Little, Brown, Boston. 2nd ed.
97. Kaufman A.R., Sivak M.V. Endoscopic ultrasonography in the differential diagnosis of pancreatic disease. Gastrointest Endosc 1989, 35:214-219.
98. Nattermann C., Goldschmidt A.J., Dancygier H. [Endosonography in the assessment of pancreatic tumors: a comparison of the endosonographic findings of carcinomas and segmental inflammatory changes]. Dtsch Med Wochenschr 1995, 120:1571-1576. [in German].
99. Glasbrenner B., Schwartz M., Pauls S., et al. Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the preoperative assessment of masses in the pancreatic head. Dig Surg 2000, 17:468-474.
100. Varadarajulu S., Tamhane A., Eloubeidi M.A. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005, 62(5):728-736. quiz 751, 753.
101. Yu X.J., Long J., Fu D.L., et al. Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray. Hepatobiliary Pancreat Dis Int 2003, 2(3):467-470.
102. Chhieng D.C., Benson E., Eltoum I., et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003, 99(6):365-371.
103. Crnogorac-Jurcevic T., Missiaglia E., Blaveri E., et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003, 201(1):63-74.
104. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003, 63(24):8614-8622.
105. Jonckheere N., Perrais M., Mariette C., et al. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Oncogene 2004, 23(34):5729-5738.
106. Juuti A., Nordling S., Louhimo J., et al. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Oncology 2003, 65(4):371-377.
107. Missiaglia E., Blaveri E., Terris B., et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 2004, 112(1):100-112.
108. Su S.B., Motoo Y., Iovanna J.L., et al. Expression of p8 in human pancreatic cancer. Clin Cancer Res 2001, 7(2):309-313.
109. Maacke H., Jost K., Opitz S., et al. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 2000, 19(23):2791-2795.
110. Biankin A.V., Morey A.L., Lee C.S., et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol 2002, 20(23):4531-4542.
111. Boltze C., Schneider-Stock R., Aust G., et al. CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections. Pathol Int 2002, 52(2):83-88.
112. Casey G., Yamanaka Y., Friess H., et al. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993, 69(3):151-160.
113. Di Sebastiano P., di Mola F.F., Di Febbo C., et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000, 47(3):423-448.
114. Liao Q., Kleeff J., Xiao Y., et al. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis. Histol Histopathol 2003, 18(2):425-433.
115. Logsdon C.D., Simeone D.M., Binkley C., et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003, 63(10):2649-2657. [erratum appears in Cancer Res. 2003;63(12):3445].
116. Mitas M., Cole D.J., Hoover L., et al. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem 2003, 49:312-315.
117. Yamaguchi Y., Watanabe H., Yrdiran S., et al. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation. Clin Cancer Res 1999, 5(5):1147-1153.
118. Sturm P.D., Rauws E.A., Hruban R.H., et al. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 1999, 5(3):629-635.
119. Stewart C.J., Burke G.M. Value of p53 immunostaining in pancreatico-biliary brush cytology specimens. Diagn Cytopathol 2000, 23(5):308-313.
120. Levy M.J., Clain J.E., Clayton A., et al. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA. Gastrointest Endosc 2007, 66(3):483-490.
121. Chari S.T., Takahashi N., Levy M.J., et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009, 7(10):1097-1103.
122. Keogan M.T., Tyler D., Clark L., et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR. Am J Roentgenol 1998, 171(6):1565-1570.
123. Rajput A., Stellato T.A., Faulhaber P.F., et al. The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease. Surgery 1998, 124(4):793-797.
124. Bares R., Klever P., Hauptmann S., et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994, 192(1):79-86.
125. Higashi T., Saga T., Nakamoto Y., et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET): usefulness and limitations in "clinical reality.". Ann Nucl Med 2003, 17:261-279.
126. Nakamoto Y., Higashi T., Sakahara H., et al. Delayed (18)F-fluoro-2-deoxy- d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000, 89:2547-2554.
127. van Kouwen M.C., Jansen J.B., van Goor H., et al. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 2005, 32(4):399-404.
128. Kajiwara M., Kojima M., Konishi M., et al. Autoimmune pancreatitis with multifocal lesions. J Hepatobiliary Pancreat Surg 2008, 15(4):449-452.
129. Sah R.P., Pannala R., Chari S.T., et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010, 8(1):91-96.
130. Chari S.T., Smyrk T.C., Levy M.J., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4(8):1010-1016. quiz 934.
131. Ghazale A., Chari S.T., Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102(8):1646-1653.
132. Choi E.K., Kim M.H., Lee T.Y., et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007, 35(2):156-161.
133. Frulloni L., Lunardi C., Simone R., et al. Identification of a novel antibody associate with autoimmune pancreatitis. N Engl J Med 2009, 361(22):2135-2142.
134. Kubota K., Kato S., Akiyama T., et al. Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features. Gastrointest Endosc 2008, 68(6):1204-1208.
135. Kamisawa T., Tu Y., Egawa N., et al. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc 2008, 68(2):358-361.
136. Deshpande V., Mino-Kenudson M., Brugge W.R., et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol 2005, 29(11):1464-1471.
137. Farrell J.J., Garber J., Sahani D., Brugge W.R. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004, 60(6):927-936.
138. Levy M.J., Reddy R.P., Wiersema M.J., et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc 2005, 61(3):467-472.
139. Mizuno N., Bhatia V., Hosoda W., et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009, 44(7):742-750.
140. Bang S.J., Kim M.H., Kim do H., et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis?. Pancreas 2008, 36(1):84-89.
141. Sugumar A., Levy M.J., Kamisawa T., et al. Utility of endoscopic retrograde pancreatogram (ERP) to diagnose autoimmune pancreatitis (AIP): an international, double blind randomized, multicenter study [abstract]. Gastrointest Endosc 2009, 69:AB124.
142. Hoki N., Mizuno N., Sawaki A., et al. Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 2009, 44(2):154-159.
143. Kamisawa T., Shimosegawa T., Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58(11):1504-1507.
144. Pannala R., Chari S.T. Corticosteroid treatment for autoimmune pancreatitis. Gut 2009, 58(11):1438-1439.
145. Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134(3):706-715.
146. Carter J.E., Nelson J.J., Eves M., Boudreaux C. Giardia lamblia infection diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol 2007, 35(6):363-365.
147. Cherian J.V., Somasundaram A., Ponnusamy R.P., Venkataraman J. Peripancreatic tuberculous lymphadenopathy: an impostor posing diagnostic difficulty. JOP 2007, 8(3):326-329.
148. Boujaoude J.D., Honein K., Yaghi C., et al. Diagnosis by endoscopic ultrasound guided fine needle aspiration of tuberculous lymphadenitis involving the peripancreatic lymph nodes: a case report. World J Gastroenterol 2007, 13(3):474-477.
149. Canto M.I., Goggins M., Yeo C.J., et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004, 2:606-621.
150. Brune K., Abe T., Canto M., et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006, 30(9):1067-1076.
151. Brentnall T.A., Bronner M.P., Byrd D.R., et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999, 131:247-255.
152. Lecesne R., Taourel P., Bret P.M., et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999, 211:727-735.
153. Arvanitakis M., Delhaye M., De Maertelaere V., et al. Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology 2004, 126:715-723.
154. Ballinger A.B., Barnes E., Alstead E.M., Fairclough P.D. Is intervention necessary after a first episode of acute idiopathic pancreatitis?. Gut 1996, 38:293-295.
155. Yusoff I.F., Raymond G., Sahai A.V. A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc 2004, 60:673-678.
156. Tandon M., Topazian M. Endoscopic ultrasound in idiopathic acute pancreatitis. Am J Gastroenterol 2001, 96(3):705-709.
157. Norton S.A., Alderson D. Endoscopic ultrasonography in the evaluation of idiopathic acute pancreatitis. Br J Surg 2000, 87(12):1650-1655.
158. Coyle W.J., Pineau B.C., Tarnasky P.R., et al. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy 2002, 34(8):617-623.
159. Liu C.L., Lo C.M., Chan J.K., et al. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis. Gastrointest Endosc 2000, 51(1):28-32.
160. Morris-Stiff G., Al-Allak A., Frost B., et al. Does endoscopic ultrasound have anything to offer in the diagnosis of idiopathic acute pancreatitis?. JOP 2009, 10(2):143-146.
161. Lee S.P., Nicholls J.F., Park H.Z. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992, 326:589-593.
162. Ros E., Navarro S., Bru C., et al. Occult microlithiasis in "idiopathic" acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991, 101:1701-1709.
163. Dahan P., Andant C., Levy P., et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut 1996, 38:277-281.
164. Wilcox C.M., Kilgore M. Cost minimization analysis comparing diagnostic strategies in unexplained pancreatitis. Pancreas 2009, 38(2):117-121.
165. Bret P.M., Reinhold C., Taourel P., et al. Pancreas divisum: evaluation with MR cholangiopancreatography. Radiology 1996, 199(1):99-103.
166. Bhutani M.S., Hoffman B., Hawes R.H. Diagnosis of pancreas divisum by endoscopic ultrasonography. Endoscopy 1999, 31:167-169.
167. Chen R.Y.M., Hawes R.H., Wallace M.B., Hoffman B.J. Diagnosing pancreas divisum in patients with abdominal pain and pancreatitis: is endoscopic ultrasound (EUS) accurate enough? [abstract]. Gastrointest Endosc 2002, 55:AB96.
168. Lai R., Freeman M.L., Cass O.W., Mallery S. Accurate diagnosis of pancreas divisum by linear-array endosonography. Endoscopy 2004, 36:705-709.
169. Vaughan R., Mainie I., Hawes R.H., et al. Accuracy endoscopic ultrasound in the diagnosis of pancreas divisum in a busy clinical setting [abstract]. Gastrointest Endosc 2006, 63:AB263.
170. Carnes M.L., Romagnuolo J., Cotton P.B. Miss rate of pancreas divisum by magnetic resonance cholangiopancreatography in clinical practice. Pancreas 2008, 37(2):151-153.
171. Catalano M.F., Lahoti S., Alcocer E., et al. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 1998, 48:580-587.
172. Irisawa A., Mishra G., Hernandez L.V., Bhutani M.S. Quantitative analysis of endosonographic parenchymal echogenicity in patients with chronic pancreatitis. J Gastroenterol Hepatol 2004, 19(10):1199-1205.
173. Das A., Nguyen C.C., Li F., Li B. Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue. Gastrointest Endosc 2008, 67(6):861-867.
174. Norton I.D., Zheng Y., Wiersema M.S., et al. Neural network analysis of EUS images to differentiate between pancreatic malignancy and pancreatitis. Gastrointest Endosc 2001, 54(5):625-629.
175. Kumon R.E., Pollack M.J., Faulx A.L., et al. In vivo characterization of pancreatic and lymph node tissue by using EUS spectrum analysis: a validation study. Gastrointest Endosc 2009, 71(1):53-63.
176. Romagnuolo J., Vela S., Hoffman B., et al. Accuracy of contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) using Definity® [abstract]. Gastrointest Endosc 2009, 69:AB324-AB325.
177. Kitano M., Sakamoto H., Matsui U., et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2008, 67(1):141-150.
178. Wilson S.R., Jang H.J., Kim T.K., Burns P.N. Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med 2007, 26(6):775-787. quiz 788-790.
179. Trillaud H., Bruel J.M., Valette P.J., et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009, 15(30):3748-3756.
180. Hocke M., Schulze E., Gottschalk P., et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006, 12(2):246-250.
181. Janssen J., Schlorer E., Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc 2007, 65(7):971-978.
182. Giovannini M., Thomas B., Erwan B., et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J Gastroenterol 2009, 15(13):1587-1593.